Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2016

Open Access 01-12-2016 | Research article

Factors affecting the delivery of community pharmacist-led medication reviews: evidence from the MedsCheck annual service in Ontario

Authors: Petros Pechlivanoglou, Lusine Abrahamyan, Linda MacKeigan, Giulia P. Consiglio, Lisa Dolovich, Ping Li, Suzanne M. Cadarette, Valeria E. Rac, Jonghyun Shin, Murray Krahn

Published in: BMC Health Services Research | Issue 1/2016

Login to get access

Abstract

Background

Medication reviews have become part of pharmacy practice across developed countries. This study aimed to identify factors affecting the likelihood of eligible Ontario seniors receiving a pharmacy-led medication review called MedsCheck annual (MCA).

Methods

We designed a cohort study using a random sample of pharmacy claims for MCA-eligible Ontario seniors using linked administrative data from April 2012 to March 2013. Guided by a conceptual framework, we constructed a generalized-estimating-equations model to estimate the effect of patient, pharmacy and community factors on the likelihood of receiving MCA.

Results

Of the 2,878,958 eligible claim-dates, 65,605 included an MCA. Compared to eligible individuals who did not receive an MCA, recipients were more likely to have a prior MCA (OR = 3.03), receive a new medication on the claim-date (OR = 1.78), be hypertensive (OR = 1.18) or have a recent hospitalization (OR = 1.07). MCA recipients had fewer medications (e.g., OR = 0.44 for ≥12 medications versus 0–4 medications), and were less likely to receive an MCA in a rural (OR = 0.74) or high-volume pharmacy (OR = 0.65).

Conclusions

The most important determinant of receiving an MCA was having had a prior MCA. Overall, MCA recipients were healthier, younger, urban-dwelling, and taking fewer medications than non-recipients. Policies regarding current and future medication review programs may need to evolve to ensure that those at greatest need receive timely and comprehensive medication reviews.
Footnotes
1
Caregivers are eligible to receive an MCA with signed consent from the patient [10].
 
Literature
1.
Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, Seger DL, Shu K, Federico F, Leape LL, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556–64.CrossRefPubMed
2.
Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107–16.CrossRefPubMed
3.
Manasse Jr HR. Medication use in an imperfect world: drug misadventuring as an issue of public policy, Part 1. Am J Hosp Pharm. 1989;46(5):929–44.PubMed
4.
Hatah E, Tordoff J, Duffull SB, Braund R. Pharmacists’ performance of clinical interventions during adherence support medication reviews. Res Social Adm Pharm. 2014;10(1):185–94.CrossRefPubMed
5.
Houle SK, Grindrod KA, Chatterley T, Tsuyuki RT. Paying pharmacists for patient care: a systematic review of remunerated pharmacy clinical care services. Can Pharm J (Ott). 2014;147(4):209–32.CrossRef
6.
Pammett R, Jorgenson D. Eligibility requirements for community pharmacy medication review services in Canada. Can Pharm J (Ott). 2013;147(1):20–4.CrossRef
7.
8.
Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65(3):303–16.CrossRefPubMed
9.
10.
11.
Dolovich L, Consiglio GP, MacKeigan L, Abrahamyan L, Pechlivanoglou P, Rac VE, Pojskic N, Bojarski E, Su J, Krahn M, Cadarette S:Uptake of the MedsCheck annual medication review service in Ontario community pharmacies between 2007 and 2013. Can Pharm J. 2016; 149(5):293–302.
12.
Chan BT, Austin PC. Patient, physician, and community factors affecting referrals to specialists in Ontario, Canada: a population-based, multi-level modelling approach. Med Care. 2003;41(4):500–11.PubMed
13.
Samoy LJ, Zed PJ, Wilbur K, Balen RM, Abu-Laban RB, Roberts M. Drug-related hospitalizations in a tertiary care internal medicine service of a Canadian hospital: a prospective study. Pharmacotherapy. 2006;26(11):1578–86.CrossRefPubMed
14.
Brooks JM, Unni EJ, Klepser DG, Urmie JM, Farris KB, Doucette WR. Factors affecting demand among older adults for medication therapy management services. Res Social Adm Pharm. 2008;4(4):309–19.CrossRefPubMed
15.
Galdas PM, Cheater F, Marshall P. Men and health help-seeking behaviour: literature review. J Adv Nurs. 2005;49(6):616–23.CrossRefPubMed
16.
17.
Doucette WR, Zhang Y, Chrischilles EA, Pendergast JF, Newland BA, Farris KB, Frank J. Factors affecting Medicare part D beneficiaries’ decision to receive comprehensive medication reviews. J Am Pharm Assoc (2003). 2013;53(5):482–7.CrossRef
18.
Bayoumi I, Dolovich L, Hutchison B, Holbrook A. Medication-related emergency department visits and hospitalizations among older adults. Can Fam Physician. 2014;60(4):e217–222.PubMedPubMedCentral
19.
Canadian Institute for Health Information: Adverse drug reaction–related hospitalizations among seniors, 2006 to 2011. Ottawa, ON; 2013.
20.
21.
Bradley F, Wagner AC, Elvey R, Noyce PR, Ashcroft DM. Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: a multi-method study. Health Policy. 2008;88(2–3):258–68.CrossRefPubMed
22.
Matheson FI, Dunn JR, Smith KL, Moineddin R, Glazier RH. Development of the Canadian Marginalization Index: a new tool for the study of inequality. Can J Public Health. 2012;103(8 Suppl 2):S12–16.PubMed
23.
24.
Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121–30.
25.
Ballinger GA. Using generalized rstimating equations for longitudinal data analysis. Organ Res Methods. 2004;7(2):127–50.CrossRef
26.
Jaccard J, Wan CK. LISREL approaches to interaction effects in multiple regression. Thousand Oaks, CA: Sage Publications; 2002.
27.
Pan W. Akaike’s information criterion in generalized estimating equations. Biometrics. 2001;57(1):120–5.CrossRefPubMed
28.
Farris KB, Ganther-Urmie JM, Fang G, Doucette WR, Brooks JM, Klepser DG, Fries DJ, Kuhle CL. Population-based medication reviews: a descriptive analysis of the medication issues identified in a medicare not-for-profit prescription discount program. Ann Pharmacother. 2004;38(11):1823–9.CrossRefPubMed
29.
Perlroth D, Marrufo G, Montesinos A, Lewis C, Dixit A, Li B, Rusev E, Ghimire E, Packard M, Olinger L, et al. Medication Therapy Management in chronically ill populations: Final Report. Baltimore, MD: Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services; 2013. Contract HHSM-500-2011-00012I/TOT0001.
30.
Shrank WH, Patrick AR, Brookhart MA. Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med. 2011;26(5):546–50.CrossRefPubMedPubMedCentral
31.
Deal H, Borden N, Wilson JA, Cooke C, Gillis J. Findings from the Nova Scotia seniors medication review program [Abstract]. CPJ/RPC. 2011;144(5):e49.
Metadata
Title
Factors affecting the delivery of community pharmacist-led medication reviews: evidence from the MedsCheck annual service in Ontario
Authors
Petros Pechlivanoglou
Lusine Abrahamyan
Linda MacKeigan
Giulia P. Consiglio
Lisa Dolovich
Ping Li
Suzanne M. Cadarette
Valeria E. Rac
Jonghyun Shin
Murray Krahn
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2016
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-016-1888-2

Other articles of this Issue 1/2016

BMC Health Services Research 1/2016 Go to the issue

Research article

Perception of quality of health delivery and health insurance subscription in Ghana

Research article

Improving the user experience of patient versions of clinical guidelines: user testing of a Scottish Intercollegiate Guideline Network (SIGN) patient version

Research article

Safe start at home: what parents of newborns need after early discharge from hospital – a focus group study

Research article

Telemedicine in diabetes foot care delivery: health care professionals’ experience

Research article

Perspectives of frontline health workers on Ghana’s National Health Insurance Scheme before and after community engagement interventions

Research article

Contextualizing learning to improve care using collaborative communities of practices